EZH2 and Miyoshi myopathy: Moreover, we previously demonstrated that MM cell lines exhibit differential sensitivity to the EZH2-specific inhibitor UNC199932, underscoring the need for novel combinatorial treatment strategies to overcome resistance and improve therapeutic efficacy.